Form 8-K - Current report:
SEC Accession No. 0001437749-24-030219
Filing Date
2024-09-30
Accepted
2024-09-30 08:22:10
Documents
16
Period of Report
2024-09-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20240929_8k.htm   iXBRL 8-K 24803
2 EXHIBIT 99.1 ex_728287.htm EX-99.1 26700
7 pic1.jpg GRAPHIC 4343
  Complete submission text file 0001437749-24-030219.txt   198385

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wint-20240930.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20240930_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20240930_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20240930_pre.xml EX-101.PRE 11584
18 EXTRACTED XBRL INSTANCE DOCUMENT wint20240929_8k_htm.xml XML 2837
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 241336754
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)